Erasca Inc (ERAS) Stock Analysis

Erasca Inc (ERAS) is a publicly traded company in the HEALTHCARE sector. It trades at $13.48, carries a market capitalization of $3.99B. This page summarizes the public market data, fundamentals, and frequently asked questions for ERAS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.48
• Market Cap: $3.99B
• EPS: $-0.93
• 52-Week High: $24.28
• 52-Week Low: $1.21

Market Sentiment

Erasca Inc currently has a Bearish sentiment score of -0.28.

About Erasca Inc

None

GNG Research Analysis

GNG Research scores Erasca Inc (ERAS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ERAS.

Frequently Asked Questions

Does ERAS pay dividends?

Erasca Inc (ERAS) does not currently pay a regular dividend.

What is ERAS's market cap?

Erasca Inc (ERAS) has a market capitalization of $3.99B with a current stock price of $13.48.